Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Keros Therapeutics Q3 EPS $(0.87) Down From $(0.60) YoY

Keros Therapeutics (NASDAQ:KROS) reported quarterly losses of $(0.87) per share. This is a 45 percent decrease over losses of $(0.60) per share from the same period last year.
byBenzinga Newsdesk
November 4, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Keros Therapeutics (NASDAQ:KROS) reported quarterly losses of $(0.87) per share. This is a 45 percent decrease over losses of $(0.60) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts